Characterization of clinical grade CD19 chimeric antigen receptor T cells produced using automated CliniMACS Prodigy system

BACKGROUND: Chimeric antigen receptor (CAR) T-cell therapy is highly effective for treating acute lymphoblastic leukemia and non-Hodgkin’s lymphoma with high rate complete responses. However, the broad clinical application of CAR T-cell therapy has been challenging, largely due to the lack of widesp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Jordan, Kimberly R, Schulte, Brian, Purev, Enkhtsetseg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181073/
https://www.ncbi.nlm.nih.gov/pubmed/30323566
http://dx.doi.org/10.2147/DDDT.S175113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181073/
https://www.ncbi.nlm.nih.gov/pubmed/30323566
http://dx.doi.org/10.2147/DDDT.S175113

Ejemplares similares